Injury
Volume 41, Issue 7 , Pages 687-692 , July 2010

Can low doses of simvastatin enhance fracture healing? An experimental study in rabbits

  • Dionysios Chissas

      Affiliations

    • 2nd Department of Orthopaedic and Trauma Surgery, ‘G. Genimmatas’ General Hospital of Athens, 154 Mesogeion Ave, 115 24 Athens, Greece
    • Corresponding Author InformationCorresponding author. Tel.: +30 6945855705; fax: +30 2107489039.
    • ,
  • George Stamatopoulos

      Affiliations

    • 2nd Department of Orthopaedic and Trauma Surgery, ‘G. Genimmatas’ General Hospital of Athens, 154 Mesogeion Ave, 115 24 Athens, Greece
    • ,
  • Dionysios Verettas

      Affiliations

    • Department of Orthopaedic and Trauma Surgery, School of Medicine, Demokritus University of Thrace, Greece
    • ,
  • Konstantinos Kazakos

      Affiliations

    • Department of Orthopaedic and Trauma Surgery, School of Medicine, Demokritus University of Thrace, Greece
    • ,
  • Apostolos Papalois

      Affiliations

    • Experimental-Research Department, Elpen Pharmaceuticals, Athens, Greece
    • ,
  • George Agrogiannis

      Affiliations

    • 1st Department of Pathology, School of Medicine, National and Kapodistrian University of Athens, Greece
    • ,
  • Athanasios Papaeliou

      Affiliations

    • 2nd Department of Orthopaedic and Trauma Surgery, ‘G. Genimmatas’ General Hospital of Athens, 154 Mesogeion Ave, 115 24 Athens, Greece
    • ,
  • Emmanouel Agapitos

      Affiliations

    • 1st Department of Pathology, School of Medicine, National and Kapodistrian University of Athens, Greece
    • ,
  • Alexia Balanika

      Affiliations

    • 2nd Department of Radiology, Attikon Hospital, School of Medicine, National & Kapodistrian University of Athens, Greece
    • ,
  • Eleftheria Papadopoulou

      Affiliations

    • Department of Materials Science, University of Patras, Greece
    • ,
  • George Anastopoulos

      Affiliations

    • 2nd Department of Orthopaedic and Trauma Surgery, ‘G. Genimmatas’ General Hospital of Athens, 154 Mesogeion Ave, 115 24 Athens, Greece
    • ,
  • Panagiotis G. Ntagiopoulos

      Affiliations

    • 2nd Department of Orthopaedic and Trauma Surgery, ‘G. Genimmatas’ General Hospital of Athens, 154 Mesogeion Ave, 115 24 Athens, Greece
    • ,
  • Antonios Asimakopoulos

      Affiliations

    • 2nd Department of Orthopaedic and Trauma Surgery, ‘G. Genimmatas’ General Hospital of Athens, 154 Mesogeion Ave, 115 24 Athens, Greece

,Accepted 5 October 2009.

References 

  1. Blum CB. Comparison of properties of four inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Am J Cardiol. 1994;73(14):3D–11D
  2. Bolego C, Baetta R, Bellosta S, et al. Safety considerations for statins. Curr Opin Lipidol. 2002;13(6):637–644
  3. Bouxsein ML, Turek TJ, Blake CA, et al. Recombinant human bone morphogenetic protein-2 accelerates healing in a rabbit ulnar osteotomy model. J Bone Joint Surg Am. 2001;83-A(8):1219–1230
  4. Chan KA, Andrade SE, Boles M, et al. Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women. Lancet. 2000;355(9222):2185–2188
  5. Gerson RJ, MacDonald JS, Alberts AW, et al. Animal safety and toxicology of simvastatin and related hydroxy-methylglutaryl-coenzyme A reductase inhibitors. Am J Med. 1989;87(4A):28S–38S
  6. Gerstenfeld LC, Wronski TJ, Hollinger JO, Einhorn TA. Application of histomorphometric methods to the study of bone repair. J Bone Miner Res. 2005;20(10):1715–1722
  7. Hacker SA, Healey RM, Yoshioka M, Coutts RD. A methodology for the quantitative assessment of articular cartilage histomorphometry. Osteoarthritis Cartilage. 1997;5(5):343–355
  8. Hatano H, Maruo A, Bolander ME, Sarkar G. Statin stimulates bone morphogenetic protein-2, aggrecan, and type 2 collagen gene expression and proteoglycan synthesis in rat chondrocytes. J Orthop Sci. 2003;8(6):842–848
  9. Lupattelli G, Scarponi AM, Vaudo G, et al. Simvastatin increases bone mineral density in hypercholesterolemic postmenopausal women. Metabolism. 2004;53(6):744–748
  10. Maeda T, Matsunuma A, Kawane T, Horiuchi N. Simvastatin promotes osteoblast differentiation and mineralization in MC3T3-E1 cells. Biochem Biophys Res Commun. 2001;280(3):874–877
  11. Maritz FJ, Conradie MM, Hulley PA, et al. Effect of statins on bone mineral density and bone histomorphometry in rodents. Arterioscler Thromb Vasc Biol. 2001;21(10):1636–1641
  12. Melton LJ. 3rd: how many women have osteoporosis now?. J Bone Miner Res. 1995;10(2):175–177
  13. Montagnani A, Gonnelli S, Cepollaro C, et al. Effect of simvastatin treatment on bone mineral density and bone turnover in hypercholesterolemic postmenopausal women: a 1-year longitudinal study. Bone. 2003;32(4):427–433
  14. Mundy G, Garrett R, Harris S, et al. Stimulation of bone formation in vitro and in rodents by statins. Science. 1999;286(5446):1946–1949
  15. O’Driscoll SW, Marx RG, Fitzsimmons JS, Beaton DE. Method for automated cartilage histomorphometry. Tissue Eng. 1999;5(1):13–23
  16. Ohno T, Shigetomi M, Ihara K, et al. Skeletal reconstruction by vascularized allogenic bone transplantation: effects of statin in rats. Transplantation. 2003;76(5):869–871
  17. Oxlund H, Andreassen TT. Simvastatin treatment partially prevents ovariectomy-induced bone loss while increasing cortical bone formation. Bone. 2004;34(4):609–618
  18. Reid IR, Hague W, Emberson J, et al. Effect of pravastatin on frequency of fracture in the LIPID study: secondary analysis of a randomised controlled trial. Long-term Intervention with Pravastatin in Ischaemic Disease. Lancet. 2001;357(9255):509–512
  19. Reid IR, Tonkin A, Cannon CP. Comparison of the effects of pravastatin and atorvastatin on fracture incidence in the PROVE IT-TIMI 22 trial—secondary analysis of a randomized controlled trial. Bone. 2005;37(2):190–191
  20. Rejnmark L, Buus NH, Vestergaard P, et al. Effects of simvastatin on bone turnover and BMD: a 1-year randomized controlled trial in postmenopausal osteopenic women. J Bone Miner Res. 2004;19(5):737–744
  21. Rejnmark L, Olsen ML, Johnsen SP, et al. Hip fracture risk in statin users—a population-based Danish case–control study. Osteoporos Int. 2004;15(6):452–458
  22. Schoofs MW, Sturkenboom MC, van der Klift M, et al. HMG-CoA reductase inhibitors and the risk of vertebral fracture. J Bone Miner Res. 2004;19(9):1525–1530
  23. Skoglund B, Forslund C, Aspenberg P. Simvastatin improves fracture healing in mice. J Bone Miner Res. 2002;17(11):2004–2008
  24. Tikiz C, Tikiz H, Taneli F, et al. Effects of simvastatin on bone mineral density and remodeling parameters in postmenopausal osteopenic subjects: 1-year follow-up study. Clin Rheumatol. 2005;24(5):447–452
  25. Wang JW, Xu SW, Yang DS, Lv RK. Locally applied simvastatin promotes fracture healing in ovariectomized rat. Osteoporos Int. 2007;18(12):1641–1650

☆ Level of Evidence II: Comparative Prospective Study.

PII: S0020-1383(09)00534-8

doi: 10.1016/j.injury.2009.10.011

Injury
Volume 41, Issue 7 , Pages 687-692 , July 2010

Article Tools

* Image Usage & Resolution